![Figure 4. Normal apoptosis and proliferation of B cells in Rap1b-deficient mice. (A) Normal apoptosis in naive Rap1b-deficient MZ B cells. Splenocytes from wild-type (+/+) and Rap1b-deficient (−/−) mice were stained with anti-IgM, anti-CD21, and anti-CD23 antibodies. The degree of TUNEL positivity in the gated MZ B cells (CD23−CD21hiIgMhi) was determined by FACS analysis. Percentages indicate TUNEL-positive cells in the gated B-cell subpopulations. Data are representative of 3 independent analyses. (B) Statistical analysis of the percentages of TUNEL-positive MZ B cells from panel A (3 mice of each genotype). (C) Normal proliferation of Rap1b-deficient MZ B cells in vivo. Wild-type and Rap1b-deficient mice were injected with BrdU every 12 hours for 4 days. Splenocytes from the mice were stained with anti-IgM, anti-CD21 and anti-CD23 antibodies. Cells were then permeabilized, fixed, and stained with FITC-conjugated anti-BrdU. The degree of BrdU positivity in the gated MZ B cells (CD23−CD21hiIgMhi) was determined by FACS analysis. Percentages indicate BrdU-positive cells in the gated B-cell subpopulations. Data are representative of 2 mice per genotype. (D) Statistical analysis of the percentages of BrdU-positive MZ B cells from panel C (2 mice of each genotype). (E) Normal proliferation of Rap1b-deficient MZ and FO B cells in response to LPS in vitro. MZ (CD23−CD21hiIgMhi) and FO (CD23+CD21intIgMlo) B cells were sorted from the splenocytes of wild-type or Rap1b-deficient mice and then stimulated with LPS for 48 hours. Proliferative responses were determined by [3H]thymidine incorporation. Data are representative of 3 independent experiments. (F) Normal proliferation of Rap1b-deficient splenic mature B cells in response to LPS, anti-IgM, or anti-IgM plus IL-4 in vitro. Splenic mature B cells were purified from the splenocytes of wild-type or Rap1b-deficient mice and then stimulated with LPS, anti-IgM or anti-IgM plus IL-4 for 48 hours. Proliferative responses were determined by [3H]thymidine incorporation. Data are representative of 2 independent experiments.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/111/9/10.1182_blood-2007-12-128140/4/zh80100819260004.jpeg?Expires=1735545684&Signature=DiKTD7kFQ-ryXOhxwHIkloQ3QRcuCMFgR70Wo07OAsGDujb8ARXjzr6OOQSCNph89xugDHsNfS3KFBC2s14xr0JL12sm7eYFUm7qVpBqpV3GFoVag1v6VxaHRt-KDKCbkEv~3H5YUP4S1cBE~xW7KUfNAG2y6nWMXe61~wt~9xAHQzLEKzGZoNi4kzKr3rjzB-HgcYKNwIXB-giui14Zrj-uAdmPjPKotLhR8T03tnKz3VwwZGONqpk6gSaEnINhW4jDfU5NbkGTx6s5vX11g3UIrB35oe3m8gR3OyGwj0gosi-qR8wBqaYPi8KK5oylx3soFC7dZkNgK9bbo889Xg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Normal apoptosis and proliferation of B cells in Rap1b-deficient mice. (A) Normal apoptosis in naive Rap1b-deficient MZ B cells. Splenocytes from wild-type (+/+) and Rap1b-deficient (−/−) mice were stained with anti-IgM, anti-CD21, and anti-CD23 antibodies. The degree of TUNEL positivity in the gated MZ B cells (CD23−CD21hiIgMhi) was determined by FACS analysis. Percentages indicate TUNEL-positive cells in the gated B-cell subpopulations. Data are representative of 3 independent analyses. (B) Statistical analysis of the percentages of TUNEL-positive MZ B cells from panel A (3 mice of each genotype). (C) Normal proliferation of Rap1b-deficient MZ B cells in vivo. Wild-type and Rap1b-deficient mice were injected with BrdU every 12 hours for 4 days. Splenocytes from the mice were stained with anti-IgM, anti-CD21 and anti-CD23 antibodies. Cells were then permeabilized, fixed, and stained with FITC-conjugated anti-BrdU. The degree of BrdU positivity in the gated MZ B cells (CD23−CD21hiIgMhi) was determined by FACS analysis. Percentages indicate BrdU-positive cells in the gated B-cell subpopulations. Data are representative of 2 mice per genotype. (D) Statistical analysis of the percentages of BrdU-positive MZ B cells from panel C (2 mice of each genotype). (E) Normal proliferation of Rap1b-deficient MZ and FO B cells in response to LPS in vitro. MZ (CD23−CD21hiIgMhi) and FO (CD23+CD21intIgMlo) B cells were sorted from the splenocytes of wild-type or Rap1b-deficient mice and then stimulated with LPS for 48 hours. Proliferative responses were determined by [3H]thymidine incorporation. Data are representative of 3 independent experiments. (F) Normal proliferation of Rap1b-deficient splenic mature B cells in response to LPS, anti-IgM, or anti-IgM plus IL-4 in vitro. Splenic mature B cells were purified from the splenocytes of wild-type or Rap1b-deficient mice and then stimulated with LPS, anti-IgM or anti-IgM plus IL-4 for 48 hours. Proliferative responses were determined by [3H]thymidine incorporation. Data are representative of 2 independent experiments.
